Clinical Trial Update: A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 safety study of HST101 in healthy Chinese participants, currently enrolling by invitation to assess safety in individuals with hypercholesterolemia-rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HST101

Snippet

Sponsor: Hasten Biopharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia, Healthy Volunteers | Phase 1 | Status: ENROLLING_BY_INVITATION